Clinical Trial Update: Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluated the efficacy of an anti-tubercular vaccine in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Anti-Tubercular Vaccine (experimental)

Snippet

Sponsor: S. Andrea Hospital | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED